Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Titel:
Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Auteur:
Rubinstein, Paul G Moore, Page C Bimali, Milan Lee, Jeanette Y Rudek, Michelle A Chadburn, Amy Ratner, Lee Henry, David H Cesarman, Ethel DeMarco, Camille E Costagliola, Dominique Taoufik, Yassine Ramos, Juan Carlos Sharon, Elad Reid, Erin G Ambinder, Richard F Mitsuyasu, Ronald Mounier, Nicolas Besson, Caroline Noy, Ariela